$0.41
+0.05 (+14.14%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+9,143.3% upside
Low Target
$25.94
Average Target
$37.99
High Target
$62.46
Current Price
$0.41
Current
$0.41
$0.41
Target
$37.99
$37.99
$25.94
$37.99 avg
$62.46
Scenario Analysis
Bear Case
$25.94
6,211.4%
Low target
Base Case
$37.99
+9,143.3%
Avg target
Bull Case
$62.46
+15,097.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.17
-81.1% from high
52-Week Low
$0.23
+78.7% from low
Target vs 52W High
$37.99
+1,650.7% vs high
Next Earnings Report
Nov 12, 2026
Today
EPS Est: $-0.12
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -13.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +112.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -38.8% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.6% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -36.1% |